The results are in line with a previous study that suggested a correlation between elevated PSMD14 expression and a higher-risk category (younger age group, ≤ 20.83 years of age), metastasis within five years, and a higher tumour grade in osteosarcoma patients [37]. Here, PSMD14 is linked to neoplasm.